Magnetic resonance imaging in neuromyelitis optica

Multiple Sclerosis Journal

Volumn 20, Issue 9, 2014, Pages 1153-1164

  Tackley, George ^a   Kuker, Wilhelm ^a   Palace, Jacqueline ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

demyelination; Devic's disease; Magnetic resonance imaging; multiple sclerosis; neuromyelitis optica; T2 lesions

Indexed keywords

AQUAPORIN 4 ANTIBODY; GADOLINIUM; AQUAPORIN 4;

AGE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CORTEX LESION; BRAIN STEM INJURY; CEREBROVASCULAR ACCIDENT; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; ETHNICITY; FINGER INJURY; GRAY MATTER; HUMAN; HYPOTHALAMUS LESION; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTIC NERVE LESION; OPTIC NEURITIS; PATHOGENESIS; RELAPSE; REVIEW; SPINAL CORD; SPINAL CORD LESION; WHITE MATTER; WHITE MATTER LESION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; OPTIC NERVE; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; BRAIN DISEASE; BRAIN LEVEL; DIFFUSION TENSOR IMAGING; IMAGE ANALYSIS; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; PERIAQUEDUCTAL LESION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; ULTRA HIGH FIELD STRUCTURAL MAGNETIC RESONANCE IMAGING;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA; OPTIC NERVE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SPINAL CORD;

EID: 84904209101     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514531087     Document Type: Review

References (64)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815 (Pubitemid 47238676)
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 1107-1118 ; 53 :
4. Kitley J, Leite MI, Küker W, et al. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol. 2013 ; 70: 1375-1381
5. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
6. Palace J, Leite M, Nairne A, et al. Interferon beta treatment in neuromyelitis optica: Increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010 ; 67: 1016-1017
7. Shimizu J, Hatanaka Y, Hasegawa M, et al. IFN?-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010 ; 75: 1423-1427
8. Jury?czyk M, Zaleski K, Selmaj K. Natalizumab and the development of extensive brain lesions in neuromyelitis optica. J Neurol. 2013 ; 260: 1919-1921
9. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988 ; 38: 180
10. Yonezu T, Ito S, Mori M, et al. 'Bright spotty lesions' on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler. 2013 ; 20: 331-337
11. Zhong X, Wang H, Bao J, et al. Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica. Chin Med J. 2012 ; 125: 270-274
12. K?yat-Atamer A, Ekizo?lu E, Tüzün E, et al. Long-term MRI findings in neuromyelitis optica: Seropositive versus seronegative patients. Eur J Neurol. 2013 ; 20: 781-787
13. Murchison AG, Kitley J, George J, et al. Spinal cord MRI features in neuromyelitis optica (NMO): Characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks.. Mult Scler. 2013 ; 19 (11 suppl). 329
14. Downer JJ, Leite MI, Carter R, et al. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?. Neuroradiology. 2012 ; 54: 279-285
15. Nakamura M, Miyazawa I, Fujihara K, et al. Preferential spinal central gray matter involvement in neuromyelitis optica: An MRI study. J Neurol. 2008 ; 255: 163-170
16. Frohman EM, Wingerchuk DM. Transverse myelitis. N Engl J Med. 2010 ; 363: 564-572
17. Calvo ÁC, Martínez MAM, Alentorn-Palau A, et al. Idiopathic acute transverse myelitis: Outcome and conversion to multiple sclerosis in a large series. BMC Neurol. 2013 ; 13: 135
18. Asgari N, Skejoe HPB, Lillevang ST, et al. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): A population-based, descriptive study. BMC Neurol. 2013 ; 13: 33
19. Kitley JL, Leite MI, George JS, et al. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012 ; 18: 271-285
20. Kitley J. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol. 2013 ; 70: 1375-1381
21. Weinshenker BG, Wingerchuk DM, Pittock SJ, et al. NMO-IgG: A specific biomarker for neuromyelitis optica. Dis Markers. 2006 ; 22: 197-206 (Pubitemid 44763273)
22. Pittock S.J., Lennon V.A., Krecke K., Wingerchuk D.M., Lucchinetti C.F., Weinshenker B.G.. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 ; 63: 390-396
23. Cabrera-Gomez JA, Kister I. Conventional brain MRI in neuromyelitis optica. Eur J Neurol. 2012 ; 19: 812-819
24. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 ; 120: 2059-2069 (Pubitemid 27493740)
25. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
26. Matthews L, Marasco R, Jenkinson M, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology. 2013 ; 80: 1330-1337
27. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation. 2012 ; 9 (14). 1-17
28. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 ; 63: 964-968 (Pubitemid 44036298)
29. Pires CE, Silva CMC da, Lopes FCR, et al. Brain MRI abnormalities in Brazilian patients with neuromyelitis optica. J Clin Neurosci. 2012 ; 19: 969-974
30. Matthews LA, Palace JA. The role of imaging in diagnosing neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2013 ; 3: 284-293
31. Huh S-Y, Min J-H, Kim W, et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler J. 2013 ;:
32. Niino M, Uesugi H, Takahashi T, et al. Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder. Intern Med Tokyo Jpn. 2012 ; 51: 809-812
33. Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 ; 68: 757-761
34. Popescu BFG, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions Nausea, vomiting, and pathogenic implications. Neurology. 2011 ; 76: 1229-1237
35. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012 ; 135: 1834-1849
36. Matsushita T, Isobe N, Matsuoka T, et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler. 2009 ; 15: 834-847
37. Ito S, Mori M, Makino T, et al. 'Cloud-like enhancement' is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009 ; 66: 425-428
38. Calabrese M, Oh MS, Favaretto A, et al. No MRI evidence of cortical lesions in neuromyelitis optica. Neurology. 2012 ; 79: 1671-1676
39. Kister I, Herbert J, Zhou Y, et al. Ultrahigh-Field MR (7 T) Imaging of brain lesions in neuromyelitis optica. Mult Scler Int. 2013 ; 2013: 1-7
40. Sinnecker T, Dörr J, Pfueller CF, et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology. 2012 ; 79: 708-714
41. Popescu BFG, Parisi JE, Cabrera-Gómez JA, et al. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 ; 75: 2103-2109
42. Tahara M, Ito R, Tanaka K, et al. Cortical and leptomeningeal involvement in three cases of neuromyelitis optica. Eur J Neurol. 2012 ; 19: e47 - e48
43. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci. 2003 ; 4: 991-1001 (Pubitemid 37486675)
44. Makino T, Ito S, Mori M, et al. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler. 2013 ; 19: 308-315
45. Matsushita T, Isobe N, Matsuoka T, et al. Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler. 2009 ; 15: 1113-1117
46. Magaña SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009 ; 72: 712-717
47. Lotze TE, Northrop JL, Hutton GJ, et al. Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008 ; 122: e1039 - e1047
48. Dimitrijevic N, Bogicevic D, Dimitrijevic A, et al. Early presentation of neuromyelitis optica. Indian Pediatr. 2012 ; 49: 924-925
49. Yavuz H, Kire?i D. Unusual manifestations of pediatric neuromyelitis optica. J Child Neurol. 2013 ; 28: 658-662
50. Storoni M, Davagnanam I, Radon M, et al. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: A novel magnetic resonance imaging scoring system. J Neuroophthalmol. 2013 ; 33: 123-127
51. Khanna S, Sharma A, Huecker J, et al. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuro-Ophthalmol. 2012 ; 32: 216-220
52. Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2011 ; 11: 535-544
53. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 ; 202: 473-477 (Pubitemid 41186945)
54. Saini H, Fernandez G, Kerr D, et al. Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity. J Neuroimmunol. 2010 ; 221: 68-72
55. Klawiter EC, Xu J, Naismith RT, et al. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Mult Scler. 2012 ; 18: 1259-1268
56. Naismith RT, Xu J, Klawiter EC, et al. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. 2013 ; 80: 2201-2209
57. Pessôa FMC, Lopes FCR, Costa JVA, et al. The cervical spinal cord in neuromyelitis optica patients: A comparative study with multiple sclerosis using diffusion tensor imaging. Eur J Radiol. 2012 ; 81: 2697-2701
58. Qian W, Chan Q, Mak H, et al. Quantitative assessment of the cervical spinal cord damage in neuromyelitis optica using diffusion tensor imaging at 3 Tesla. J Magn Reson Imaging. 2011 ; 33: 1312-1320
59. Liu Y, Duan Y, He Y, et al. A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler. 2012 ; 18: 1013-1021
60. Rocca MA, Agosta F, Mezzapesa DM, et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology. 2004 ; 62: 476-478 (Pubitemid 38200865)
61. Pichiecchio A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of neuromyelitis optica: A multiparametric approach. Mult Scler. 2012 ; 18: 817-824
62. MatthewsLKolindSLeiteM. Can quantitative MRI measures of white matter integrity distinguish neuromyelitis optica from multiple sclerosis? (Unpublished paper). Presented at White Matter Study Group Meeting. Reykjavik, Iceland August 2011, 21-26.
63. Seze J de, Blanc F, Kremer S, et al. Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2010 ; 81: 409-411
64. Ciccarelli O, Thomas DL, Vita E, et al. Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica. Ann Neurol. 2013 ; 74:: 301-305